17h
Live Science on MSN'Fascinating' Viking Age inscription reveals who owned immensely valuable 'Galloway Hoard'A newly deciphered inscription suggests the immense "Galloway Hoard" found in Scotland over a decade ago was held in common.
Two healthcare stocks in the white-hot weight-loss segment tanked on Monday as one of their rivals zoomed higher. The ...
A famed Viking-age silver hoard discovered in Scotland may have belonged to an entire community of people, rather than one ...
Viking is continuing to invest in its fleet, aided by expected industry growth in the next few years. Read more to see ...
Viking Therapeutics stock jumped higher last year because it looks like a dual GLP-1/GIP agonist it's developing could ...
2d
KELO Sioux Falls on MSNBalow win secures Viking victory over MavericksAction came down to the final weight class of the afternoon and did not disappoint, as a victory at 285 pounds completed the ...
And with a growing number of companies in the GLP-1 space, investors may be losing interest in the stock. Could Viking's ...
USA TODAY on MSN13d
Princess, Viking gastrointestinal outbreaks sicken 140+ cruise guests, crewAmong 1,894 guests aboard Princess’ Coral Princess ship, 59 reported being ill during its current voyage, along with 12 crew ...
Citi analyst David Lebowitz initiated coverage of Viking Therapeutics (VKTX) with a Neutral rating and $38 price target Viking’s VK2735 is an ...
What a year it was for former Vikings tight end Nick Muse, who got to shotgun a beer with Saquon Barkley after the Eagles' Super Bowl LIX victory on Sunday.
Viking Therapeutics (NASDAQ:VKTX – Get Free Report)‘s stock had its “buy” rating reissued by analysts at HC Wainwright in a research report issued on Thursday,Benzinga reports. They currently have a ...
Truist lowered the firm’s price target on Viking Therapeutics (VKTX) to $95 from $120 and keeps a Buy rating on the shares. The company’s Q4 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results